This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, Université Joseph Fourier. Active years: 2012-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 8,827 
1 out of 112 Years Active: 2012-2018
Title: Anaïs Pujol: Innovator in Neurodegenerative Disease Treatment
Introduction
Anaïs Pujol is a prominent inventor based in Andernos les Bains, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 2 patents, her work focuses on innovative compounds that can aid in the diagnosis and treatment of serious health conditions.
Latest Patents
One of her latest patents is titled "Cyclodecapeptide compounds for use as drugs." This invention relates to novel cyclodecapeptide compounds designed for the diagnosis, prevention, and treatment of neurodegenerative diseases, including Wilson's disease and Alzheimer's disease. Additionally, it addresses the treatment of poisoning from metal ions, such as copper and mercury. The patent also includes pharmaceutical compositions that utilize these compounds as active principles.
Another significant patent is "Chelating agents of metal ions, their methods of preparation and their applications." This invention involves compounds that serve as metal-ion-chelating agents or depolluting agents. It also covers precursor compounds and labeled compounds derived from the main compounds. The applications of these compounds extend to their use as medicaments for the diagnosis, prevention, and treatment of neurodegenerative diseases.
Career Highlights
Anaïs Pujol has worked with notable organizations, including the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and Université Joseph Fourier. Her experience in these institutions has contributed to her expertise in the field of pharmaceuticals and innovative drug development.
Collaborations
Throughout her career, Anaïs has collaborated with esteemed colleagues such as Pascale Delangle and Pascal Dumy. These partnerships have further enriched her research and development efforts.
Conclusion
Anaïs Pujol is a remarkable inventor whose work in developing novel compounds for treating neurodegenerative diseases showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against these challenging health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile